Anthony Sanzone, MD
Orthopaedic Surgery · Chula Vista, CANPI 1992747059
Payments from drug & device makers
Across 33 payments — averaging $749.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$11K
- Arthrex$8K
- Trice Medical, Inc.$3K
- BD$1K
- US Implant Solutions, LLC$833
- Solventum Corporation$600
- plus $570 from 6 others
What the payments were for
- Consulting fees$13,42354%
- Speaking & faculty fees$8,57535%
- Travel & lodging$1,0954%
- Food & beverage$1,6287%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 10 | $11,104 |
| Arthrex | 5 | $7,831 |
| Trice Medical, Inc. | 3 | $2,783 |
| BD | 1 | $1,000 |
| US Implant Solutions, LLC | 5 | $833 |
| Solventum Corporation | 1 | $600 |
| Kerecis Limited | 1 | $165 |
| Myoscience Inc. | 1 | $156 |
| Osteocentric Technologies, Inc. | 1 | $99 |
| Elevate Surgical Co | 3 | $98 |
| Acumed LLC | 1 | $37 |
| Orthofix Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DHS$9,673
- IM NAILS$9,673
- INSTRUMENTS$9,673
- TFN ADVANCED$9,673
- Segway blade or mieye camera$2,700
- NA$1,350
- Kerecis Omega3 Marigen$658
- PREVENA$600
- V.A.C. VERAFLO$600
- V.A.C. VERAFLO CLEANSE CHOICE$600
- ABTHERA$600
- TFN-Advance$450
- Kerecis Omega3 SurgiClose$165
- IOVERA SYSTEM$156
How this compares
$24,721 in reported general payments places this provider in the 80th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 18 | $276 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $268 |
| Tramadol Hcl | 20 | $125 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chula Vista
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.